Victoria’s Secret & Co. (NYSE: VSXY) — A Share-Losing Mall Icon, Re-Rated Fivefold and Still Priced for Permanence

An independent equity-research note · Published: 2026-07-14 · An update to the note published 2026-07-03

Note on ticker: the company changed its NYSE symbol from VSCO to VSXY effective June 2, 2026 (same CUSIP; no shareholder action). Fiscal years end late January/early February; “FY2025” refers to the year ended January 31, 2026 unless noted.

⚡ Claude’s Take

This block is the author’s own subjective opinion and general information only — not investment advice. The analysis that follows takes no position and carries no price target; this block is the sole exception.

Verdict: HOLD / do not chase here / not a short. Unchanged from the 2026-07-03 note. Great trade, wrong entry — just ~11% less wrong. The turnaround under CEO Hillary Super is real — four straight positive-comp quarters, 240bps of gross-margin recovery on a genuine “promo detox,” and international momentum — but the market has already priced it and then some. Since that note, the stock has slipped from ~$88 to ~$78 (July 10 close), ~11.5% off its June-26 all-time high of $88.50, on no news of substance: no new filings, no new quarter (Q2 FY2026 doesn’t report until roughly late August). The pullback modestly de-rates the name — trailing GAAP P/E ~36x→~32x, forward adjusted P/E ~21x→~19x, funded EV/EBITDA ~15–16x→~13x — but it remains at the 99th percentile of its own P/E history and a premium to every cheaper, higher-quality apparel peer (American Eagle/Aerie ~7x EBITDA, Gap ~7x, Urban Outfitters ~9x). This is still a share-losing incumbent — ~20% of US intimates today versus ~33% a decade ago — in a low-barrier, promotional category, whose trailing earnings are flattered by a one-time $69M litigation gain and a 9% tax rate, and whose lead activist (BBRC/Brett Blundy, ~13%) sold into the June top while management (~0.5% ownership) has bought nothing on the way up.

Framing (unchanged): a special-situation re-rating — turnaround + a ~22%-of-float short squeeze + activist/takeover optionality — that overshot fundamentals, not a compounder emerging from a moat. On forward adjusted EPS (~$4.10–4.20 if the raised FY2026 guide is hit and I normalize the tax rate) the stock is ~19x — better than the ~21x a fortnight ago, but still defensible only if 8%+ operating margins prove durable rather than cyclical. I’d own this business in the ~$45–55 zone (~11–13x forward adjusted EPS, in line with peers), roughly where insiders/activists were actually transacting — and at ~$78 the stock is still ~40–70% above the top of that zone. The ~11% pullback narrows the gap; it does not close it. Conviction: medium. Tag: “The turnaround is real; the re-rating still leads it.”

• What flips me bullish: durable double-digit comps with operating margin pushing through 8–9% for a full cycle — proof the brand has regained real pricing power, not just lapped easy comparisons and cut promotions.
• What flips me bearish: comps rolling back toward flat, the promo detox reversing, tariffs re-compressing margin, or BBRC dumping its 13% — any of which would collapse the multiple toward the peer 9–11x, i.e., the mid-$40s or lower.

Changes since the 2026-07-03 note

In the 11 days since coverage was initiated, nothing about the business changed and the call does not change. The full diff:

• No new fundamentals. No new SEC filings since that note (EDGAR since 2026-07-03 is empty); the last filings — a June-30 Form 4, a June-15 8-K, the June-5 Q1 10-Q — were already in the prior memo. The next data point, Q2 FY2026, is roughly six weeks out (~late Aug/early Sept). The turnaround, the QoE caveats, the moat verdict, the capital-allocation critique, and the activist outcome are all as previously reported.
• Price: a modest give-back. VSXY fell from ~$88 to ~$78 (−11.5% off the $88.50 ATH). The move de-rates the multiple by roughly a tenth (trailing P/E ~36x→~32x; forward adjusted ~21x→~19x; funded EV/EBITDA ~15–16x→~13x; P/S ~1.1x→~0.97x) but leaves it in the 99th-percentile-of-own-history band and still above peers.
• Sell-side got more bullish into the dip. Morgan Stanley reinstated Overweight with a $99 price target (July 6); J.P. Morgan is at $88. Street targets now sit above the stock — consensus continues to underwrite the bull case, exactly the “priced for the bull scenario” condition flagged in that note.
• A supply-chain corroboration. HK-listed Regina Miracle International, a core Victoria’s Secret bra OEM, reported (July 6) a profit lift attributed partly to VS orders — an independent, third-party read-through consistent with VS’s volume/order momentum (mildly bullish; a corroboration of the demand recovery, not a thesis change).
• Factor track record cooled with the price. The trailing-1-year annualized return eased from ~+386% to ~+321% (Sharpe ~4.1); the 3-year maximum drawdown of −69% is unchanged. Still an idiosyncratic, high-specific-vol special situation, not a factor trade.

Net: the prior thesis stands verbatim; the stock is ~11% cheaper and the risk/reward is marginally better, but not enough to move the call off HOLD / don’t-chase.

📈 Stock Price Action — Five-Year Event Map

Factual price history and its drivers. Price moves are FACT; attributed causes are INTERPRETATION. No recommendation, no price target, no chart-reading — the opportunity judgment lives in Claude’s Take above.

The arc in plain numbers. VSXY began regular-way trading around $69 after its August 2021 spin from L Brands — effectively the high-water mark of its entire history. It then bled for two years to an all-time low of $14.30 (October 5, 2023) as post-COVID intimates demand normalized and the brand lost relevance, bottomed again near $17.70 in July 2025 on a cyberattack and tariff shock, and re-rated violently to an all-time high of $88.50 on June 26, 2026 — roughly a 5x move in ~11 months. It has since given back ~11%, closing at ~$78.36 on July 10, 2026 — still near the top of its post-spin range, with a 52-week range of roughly $17.70–$88.50.

Cycle narrative. (1) The spin handed shareholders a mid-$60s stock at the top; (2) two years of demand normalization and brand erosion took it to $14.30; (3) the March 2024 guide-down was its worst single day on record; (4) a cyberattack plus tariff fears marked maximum pessimism near $17.70 — the launch pad. The re-rating then arrived in four earnings-driven up-legs: (5) the Q3 FY2025 beat proved comps had inflected; (6) the Q4 beat confirmed durability; (7) the Q1 FY2026 double-beat, landing days before a contested proxy vote into a float ~22% short, produced the company’s largest one-day gain ever (~+47%); and (8) the incumbent board’s decisive proxy win plus analyst target hikes carried the stock to $88.50. (9) Since the June-26 peak the stock has drifted back ~11–12% to ~$78 on nothing more than profit-taking and a cooling squeeze — there has been no fresh catalyst in either direction. A telling coda from the ascent: the activist whose accumulation helped drive it, BBRC, sold 276,171 shares at $88.50 on June 26 — trimming into the exact high. Every up-leg was a real earnings event amplified by a squeeze and by unresolved takeover/activist optionality; none was driven by top-line growth beyond low-double-digit comps off depressed bases.

1. Executive Summary

Victoria’s Secret & Co. is the world’s largest intimate-apparel retailer — Victoria’s Secret, PINK, an “industry-leading” beauty business, and the acquired digitally-native brand Adore Me — generating $6.55B of FY2025 net sales across ~793 North American stores, a flat e-commerce channel, and a capital-light international franchise/JV network. It is also a company whose revenue is ~16% below its 2016 peak (~$7.78B) and whose share of US intimates has fallen from ~33% (2013) to ~20% (2024). The five-year equity story is not growth; it is a collapse-and-recovery: earnings fell from a $646M post-stimulus peak (FY2022) to a $109M trough (FY2024), and have since recovered to $161M (FY2025) as new CEO Hillary Super’s “Path to Potential” turnaround took hold.

The turnaround is genuine. FY2025 delivered four consecutive positive-comp quarters, and Q1 FY2026 (reported June 2, 2026) was a blowout: net sales +15% to $1.56B, comps +13%, adjusted operating income +153% to $80M, adjusted EPS $0.60, and gross margin +240bps to 37.6% on a deliberate “promo detox” (fewer promotions, more regular-price selling, AURs up mid-single-digits). Management raised full-year guidance to sales of $7.03–7.13B and adjusted operating income of $550–580M. International grew 36%.

But the market re-rated the stock ~5x off its July-2025 low to an all-time high of $88.50, and even after a ~11% pullback to ~$78 it trades at the richest P/E (~32x trailing GAAP, 99th own-history percentile) and near-richest P/S (~0.97x, 98th percentile) of its entire public history — a premium to cheaper, higher-quality apparel peers (AEO ~7x EV/EBITDA, GAP ~7x, URBN ~9x). Three facts temper the bull narrative: (1) trailing earnings are quality-impaired — FY2025 operating income was flattered by a one-time $69M interchange litigation gain and net income by a 9.2% tax rate (a $24M valuation-allowance release); (2) the moat is narrow and eroding — no pricing power (36% gross margin, heavy promotion), falling share, a flat DTC channel, and a $120M write-down of Adore Me (the acquisition meant to buy back digital relevance); and (3) the capital-allocation and insider signals are negative — buy-high/stop-low buybacks, ~0.5% insider ownership, no management buying on the run, and the lead activist (BBRC, ~13%) now selling after losing the June proxy fight.

On forward adjusted EPS (~$4.10–4.20 if the raised guide is met and the tax rate normalizes) the stock is a more defensible ~19x — but that still embeds durable 8%+ margins and continued double-digit comps from a structurally challenged, share-losing incumbent. The setup is a special-situation re-rating (turnaround + short squeeze + activist optionality) that has run ahead of the fundamentals; the recent 11% give-back has not changed that. This memo takes no position; the analysis below lays out why the business is real, why the moat is not, and what the price now requires to be true.

2. Business Overview

What it does. Victoria’s Secret & Co. is a specialty retailer of women’s intimate apparel, loungewear, sport, swim, and prestige beauty (fragrance and body care). It sells through three consumer-facing brands — Victoria’s Secret (its “sexy, glamorous” flagship), PINK (a younger, collegiate-lifestyle line), and Adore Me (a digitally-native intimates brand acquired in early 2023, which brought with it DailyLook, a subscription styling service) — plus a beauty business management calls “industry-leading.” The company describes itself as “the world’s largest intimate apparel company.” It employs roughly 30,000 associates (~12,000 full-time and ~21,000 part-time), reflecting a labor-heavy, mall-store model, and is headquartered in Reynoldsburg, Ohio.

How it makes money — three channels, one segment. VSXY reports as a single reportable segment (“designed to seamlessly serve customers worldwide through stores and digital channels”). The FY2025 revenue disaggregation:

Three features of this table matter more than the headline +5%. First, North America stores (54% of the business) remain below their FY2023 level — three years with no net progress in the core. Second, Direct is exactly flat at $2,042M for two straight years and up only ~1.3% versus FY2023 — a striking stall for a “digital” retailer and evidence the e-commerce channel has stopped compounding. Third, all of FY2025’s +$323M growth came from International (+$207M / +27%) plus a modest +3% NA-store comp — and the International figure is partly a reporting artifact: beginning Q3 2025, ex-US direct fulfillment was reclassified into the International line alongside consolidated China-JV sales, franchise royalties, and wholesale. The organic international growth rate is real but smaller than +27%.

Recurring vs. non-recurring. Apparel retail is inherently transactional — there is little contractual recurring revenue. The most annuity-like slice is the international franchise/license/wholesale stream (~15% of sales): more than 560 partner-operated stores across ~70 countries paying royalties “generally low-double-digits to low-teens” as a percentage of partner sales, on ~10-year franchise terms, plus strategic joint ventures in China and the UK. This is the highest-quality, most capital-light part of the model — but it is the smallest.

The store fleet is being shrunk, not grown. Company-operated stores (including the consolidated China JV) fell to 858 (Jan 2026) from 882 (Feb 2025), 907, and 915 in prior years; the US company-operated count is 766 (down from 782), plus 24 in Canada. Selling square footage declined ~2% year-over-year. The offset — and a genuine bright spot — is recovering productivity: sales per selling square foot rose to $624 (+6%) and sales per average store to ~$4,305K (+7%). In short, VSXY is a mature, contracting-footprint retailer trying to do more with fewer, more-productive doors, with growth concentrated in a small, capital-light international engine and a beauty attach business whose revenue it does not separately disclose.

3. Industry Dynamics

A growing category that VSXY keeps getting a smaller slice of. The US women’s intimate-apparel/lingerie market is estimated at roughly $18–24B in 2025, growing at a mid-single-digit CAGR (~4.5–7%), with online the fastest-growing channel (~7.8%). That is a perfectly serviceable end market — for the players taking share. VSXY’s core North American business has been flat-to-down over the same period, which frames the single most important structural fact about this company: it is losing share in a growing market.

The share-loss trajectory. VS and PINK together held roughly one-third (~33%) of US intimates in 2013; by 2024, external estimates put the two brands at ~20% — a loss of ~13 percentage points, about a third of its share, in roughly a decade, and steeper still against the ~50–60% dominance VS held in the branded mall-bra sub-segment at its mid-2010s peak. Tellingly, the 10-K never quantifies share, asserting only that “their combined market share in the intimates category remains strong” and is “a significant competitive advantage” — a soft, unquantified claim that runs opposite to the external trend.

Why the share left — a textbook capital cycle. Through the Marathon “Capital Returns” lens, VSXY’s mid-2010s economics (~$7.8B revenue, high-teens-to-20%+ operating margins under L Brands) were a beacon for new capital. Barriers to entry in intimates are low: contract manufacturing is available to anyone, DTC logistics have been commoditized by Shopify-era infrastructure, and Instagram/TikTok replaced the mall and the catalog as the customer-acquisition channel. A wave of well-funded insurgents — Aerie, Skims, Savage X Fenty, ThirdLove, Knix, Cuup, Parade, Lively — flooded in on a body-positive/inclusive-sizing counter-position to VS’s “Angels” imagery. That is supply-side mean reversion in its purest form: high incumbent returns attract entry, entry competes away share and margin. VSXY’s operating margin today (~4.1% GAAP / ~6.2% adjusted) is a fraction of its L Brands-era self, exactly as the capital-cycle framework predicts.

Structural headwinds compound the competitive ones. More than half of sales are still tied to North American physical stores, exposing VSXY to secular mall-traffic decline. The category is heavily promotional, which caps pricing power industry-wide. And the channel shift to online — where VSXY’s Direct line is flat and it enjoys no structural advantage — favors the digitally-native insurgents. Tariffs are an additional live pressure: VSXY absorbed ~$85M of operating-income drag in FY2025 and ~$14M (90bps) in Q1 FY2026, and sources the bulk of product from Asia. (The July-2026 Regina Miracle supplier note — a key VS bra OEM reporting a profit lift on VS orders — is a reminder that the sourcing base sits almost entirely in Asia and is tariff-exposed.)

Verdict: structurally challenged for the incumbent. The lingerie pie grows, but it is fragmented, low-barrier, promotional, and mall-exposed — a market where scale incumbency is being competed away rather than defended. This is an attractive arena for a nimble insurgent and a hostile one for a legacy share-loser. VSXY is on the wrong side of that divide.

4. Competitive Position

The central question is whether VSXY possesses a durable competitive advantage. Run through Greenwald’s taxonomy, the honest answer is narrow and eroding — closer to no durable moat.

Intangibles / brand — the historical moat, impaired and only partly rebuilt. VS’s brand was genuinely damaged in 2018–2020: the “Angels”/objectification backlash, the Les Wexner/Epstein association, and a loss of cultural relevance as the culture moved toward inclusivity. The rebuild under CEO Hillary Super — hired in August 2024 directly from Rihanna’s Savage X Fenty, i.e., from the insurgent that took its share — is real but incremental: the Victoria’s Secret Fashion Show returned in October 2024 and October 2025, and marketing has been repositioned around a broader body of customers. But a brand moat must ultimately show up as pricing power, and VSXY’s does not: the business remains heavily promotional and gross margin sits in the mid-30s (~36.4%). The brand still drives awareness and traffic; it does not command a durable price premium. It is a weakened intangible asset, not a fortress.

Economies of scale — largest, but scale is not converting to advantage. VSXY is the biggest intimates player, yet its operating margin is ~4–6% and its fleet is shrinking. Greenwald’s scale advantage requires stable or rising share within a bounded market; VSXY’s share is falling, which specifically fails the market-share-stability test that distinguishes a genuine scale moat from mere size. Sourcing scale exists but shows up nowhere in the P&L as a widening cost gap against Aerie or Skims.

Switching costs and network effects — none. Intimates carry essentially zero switching cost. The loyalty program and “engaged social community” trim customer-acquisition cost at the margin but lock in no one. There are no network effects.

Direct comparison, with numbers. VSXY competes against:

• Aerie (American Eagle) — the share-taker. Aerie has compounded double-digits for a decade on inclusive sizing; brand revenue is ~$1.7B+, with Aerie comps +9% in FY2025 (+23% in Q4), and Aerie+Offline now ~39% of AEO’s total. This is the mirror image of VS’s flat core.
• Skims (Kim Kardashian) — the premium insurgent. Approaching ~$1B in annual sales, valued at $5B in a November 2025 round led by Goldman Sachs Alternatives, now opening physical stores. Six years old.
• Savage X Fenty (Rihanna) — ~$1B, part of a Fenty portfolio valued ~$3.8B — and, pointedly, the alma mater of VSXY’s own CEO.
• A long tail of DTC niche brands (ThirdLove, Knix, Cuup, Parade, Lively), plus lululemon (encroaching via Align/underwear basics), Hanesbrands (Bali/Maidenform/Playtex in the mass/department channel), Gap/Old Navy, and Amazon private label at the value end. Internationally: Marks & Spencer (UK bra leader), Hunkemöller, and Intimissimi/Calzedonia.

The Adore Me tell. VSXY paid ~$400M upfront (~$591M all-in) for Adore Me in late 2022 to buy digitally-native, try-at-home capability it could not build. In FY2025 it recorded a $120M impairment of Adore Me long-lived assets plus $36M of Adore Me/DailyLook fulfillment-center restructuring — a ~30% write-down two-to-three years post-deal. This is direct evidence that acquiring a moat did not work: the insurgents’ advantage was brand and positioning, not something VSXY could purchase and integrate.

Verdict: no durable advantage. VSXY retains residual strengths — still #1 share (~20%), a globally recognized if damaged brand, ~793 productive NA stores, a genuinely attractive capital-light international royalty stream, and a beauty attach business — so it is not a zero-moat commodity retailer. But none of these convert to the financial signatures of a real moat: no pricing power, falling share, flat DTC, ~4–6% operating margins, and a written-down acquisition. This is a turnaround/self-help story dependent on execution against structurally stronger, faster-growing competitors — not a compounder defending a castle.

5. Growth History and Forward Opportunities

History: no growth, then collapse-and-recover. Over five years, revenue has been remarkably flat: $5.41B (FY2021, COVID-disrupted) → $6.79B (FY2022, stimulus peak) → $6.34B → $6.18B → $6.23B → $6.55B (FY2025). The earnings line, by contrast, is a violent round-trip: net income to VS&Co shareholders went −$72M → $646M → $348M → $109M (trough, FY2024) → $165M → $161M (FY2025), and operating income −$101M → $870M → $478M → $246M → $310M → $271M. The FY2022 peak was a stimulus- and scarcity-driven anomaly (40.7% gross margin, 12.8% operating margin) that has no bearing on normalized earnings power; the FY2024 trough marked maximum operational and brand distress. The “growth” the equity has celebrated since is really margin and earnings recovery off that trough, not top-line expansion.

The composition of recent growth. As detailed above, essentially all of FY2025’s +$323M came from International (+27%, partly reclassification) and a +3% NA-store comp; the core NA store base is below its FY2023 level and Direct is flat. The FY2025→Q1 FY2026 acceleration (Q4 comps +8%, Q1 comps +13%) is genuine and broad-based — VS, PINK, and Beauty all grew double-digits in Q1 — but it is comping depressed prior-year periods and is being achieved partly through the promo detox (higher AUR on fewer units) rather than unit/traffic surges. The July-2026 Regina Miracle supplier print — a VS bra vendor whose profit rose on VS orders — is a mild third-party corroboration that unit/order flow to the core bra category is genuinely recovering, though it says nothing about pricing durability.

Forward opportunities (management’s “Path to Potential,” four pillars):

1. Reassert bra authority — the core, highest-margin category; bras grew low-double-digits in Q1.
2. Recommit to PINK — re-energize the younger-customer franchise that had drifted.
3. Grow beauty, sport, and swim — higher-frequency, adjacency-driven attach categories.
4. Brand projection / modernized go-to-market — the Fashion Show, faster lead times, digital/social. Plus a real international runway: China (a “meaningful growth opportunity,” strong digital/social engagement) and continued franchise expansion across ~70 countries on capital-light terms.

Quality of the growth. The recovery is high-rate but questionable-quality and likely cyclical: it rests on lapping easy comparisons, a promotional pullback whose durability is unproven, and margin recovery from a distressed base — not on winning share back from Aerie/Skims (VSXY’s share is still ~20% and not visibly rising). The forward guide (sales $7.03–7.13B, i.e., ~7–9% growth) would be the first year of genuine top-line progress in half a decade — but it must be delivered against tariff headwinds and structurally stronger insurgents. Verdict: real near-term momentum of low-to-mid quality; not yet evidence of durable, share-gaining, secular growth.

6. Financial Quality

Margins: recovering, but off a weak base and with messy quality. Gross margin has been range-bound in the mid-30s — 36.4% (FY2025), 36.7%, 36.3% — a promotional, un-moat-like level (contrast the 40.7% of the FY2022 peak). The genuinely encouraging signal is the quarterly inflection: gross margin ran 35.0% (Q1 FY25) → 35.6% → 36.4% → 37.7% → 37.5% (Q1 FY26), +240bps year-over-year in the latest quarter, and operating income in Q1 jumped from $20M to $76M. That is the promo detox working. But full-year operating margin was just 4.1% GAAP / ~6.2% adjusted — structurally weak specialty-retail economics.

Quality of earnings — normalize before you capitalize. FY2025’s reported figures are flattered by non-recurring items that the bull narrative (and the proxy-winning “turnaround is working” story) partly rests on:

• +$69M credit-card interchange litigation settlement gain, booked in SG&A — inflating reported operating income of $271M (ex-gain ≈ $202M).
• A 9.2% effective tax rate (versus 23.6% prior), aided by a $24M China-JV deferred-tax valuation-allowance release — inflating net income.
• $28M of the $189M consolidated net income is noncontrolling interest (the China JV partner’s share); VS&Co shareholders’ net income is $161M, not $189M.
• Offsetting charges: the $120M Adore Me impairment and $36M restructuring, which the company’s non-GAAP “adjusted operating income of $403M” adds back — but that adjusted base still carries the $69M one-time gain and benefits from the sub-10% tax rate.

Scrubbing both the litigation gain and the abnormal tax rate, “clean” trailing adjusted EPS is closer to ~$1.80–2.20 than the headline $3.00 (and the trailing GAAP EPS is just $2.44) — which at ~$78 implies a trailing clean P/E in the ~36–44x range, not the ~26x the headline suggests. The FORWARD picture is better: the raised FY2026 guide (adjusted operating income $550–580M) at a normalized ~24% tax rate implies ~$4.10–4.20 adjusted EPS (~19x at ~$78), but that requires delivering a ~40% operating-income ramp.

Cash flow — real and healthy. Operating cash flow was $499M in FY2025 (up from $425M); capex was $187M (FY2024: $178M), leaving free cash flow of ~$312M (~$3.7/share); trailing-twelve-month free cash flow (through Q1 FY2026) is roughly $574M. Stock-based compensation was $55M. Cash conversion cycle ~59 days; inventory $1,071M, well-managed. Free cash flow comfortably covers interest and the (nonexistent) dividend.

Returns on capital — optically huge, actually modest. ROIC as computed is ~6.5% (FY2025) — roughly at or below cost of capital, consistent with a no-moat business. Reported ROE looks enormous (38% and, in prior years, into the hundreds of percent) but is a balance-sheet artifact: VS&Co equity is tiny ($856M) and was near-zero to negative in FY2023–24 after the spin loaded the company with goodwill/intangibles and lease liabilities. Tangible book value per share is just ~$3.71 (and was negative in FY2023–FY2025). The high ROE is not a quality signal; the ~6.5% ROIC is the honest read.

Balance sheet — sound on funded debt, lease-heavy. Year-end cash of $518M against ~$975M funded debt — a single $600M 4.625% senior notes tranche (due July 2029), a $379M term loan (floating ~6.49%, due Aug 2028), and an undrawn $750M ABL revolver (extended to May 2030 in a favorable 2025 refi). Net funded debt was only ~$457M (~0.9x EBITDA) at year-end; note cash is seasonally lower mid-year (~$207M at the Q1/May balance after the $100M buyback, Adore Me earnout, and inventory build), lifting interim net funded debt toward ~$0.6–0.8B, with no near-term maturity wall. The real leverage is the ~$1.8–1.9B of lease liabilities; on a rent-capitalized basis, adjusted debt/EBITDAR is ~2.8–3.2x — manageable, but a fixed-charge sensitivity if comps deteriorate. Verdict: economics improve modestly with the margin recovery, but this is a structurally low-return, cash-generative, lease-levered specialty retailer — not a high-quality compounder.

7. Capital Allocation

Capital allocation is the weakest link in the VSXY story, and the substance of the activist critique is fair even though the activists lost the vote.

Buybacks — buy high, stop low. VSXY repurchased ~$625M of stock in 2022–2023 — much of it near post-COVID highs — then stopped entirely: $0 in FY2024 and FY2025 (the only “repurchases” since were shares withheld for tax on vesting RSUs). The $250M buyback authorized in March 2024 remained largely unused. Capital instead went to Adore Me earnout payments and de-facto deleveraging. This is the textbook value-destructive pattern — aggressive repurchase into strength, dormancy into the very weakness ($14–20 in 2024–25) when the stock was cheap. Notably, the company did resume buying in Q1 FY2026 — 2.2M shares for $100M at ~$45 — which in hindsight was well-timed, though it again followed the price up rather than leading it, and ~$150M remains authorized.

M&A — a large, unproven, now-impaired deal. Adore Me (~$591M all-in) was acquired to buy digital/try-at-home capability as the core deteriorated. Two-to-three years later it carries a $120M impairment and $36M of restructuring — a ~30% write-down. The earnout is fully paid (no longer distorting cash flow), but the return on ~$591M is unproven and is the centerpiece of the activist case. The one bright spot is the China JV, now profitable ($28M of net income, up from $4M), though a third of its earnings leak to the partner.

Dividends — none. No dividend since the 2021 spin. Given the ~6.5% ROIC and the growth investment needs, retaining cash is defensible; a dividend is not the issue.

Compensation and incentives — tilted to size, not per-share value. CEO Hillary Super’s FY2025 total pay was $14.4M (with ~$5.75M sign-on equity and a $1.0M cash hire bonus in FY2024; ~$22.9M for her first ~16 months). The short-term incentive is weighted 75% adjusted operating income / 25% net sales (paid at 154% of target in FY2025); the long-term plan uses three-year internal operating-income goals plus relative TSR. The proxy explicitly frames incentives around “being a growth company through the use of operating income and net sales” — i.e., rewarding absolute scale, not ROIC or per-share value. Relative TSR (a per-share check) is only a minority of the LTI. An open question is whether the STIP’s adjusted-operating-income base excluded the $69M litigation gain; the proxy does not clearly show that it did.

Insider ownership and behavior — thin and non-confirming. All directors and executive officers together own just ~413,850 shares (~0.5%); CEO Super personally holds ~51,620 shares (~$4M at ~$78) against $14M/year of pay — modest skin in the game for a turnaround leader. On the 5x run, management bought nothing in the open market (Form 4 activity is grants and tax-withholding); the only meaningful open-market accumulation was BBRC (the activist) buying ~2.16M shares in March–April 2025 into weakness — and that buyer is now selling (~1.4M shares trimmed in June 2026, including 276,171 at the $88.50 high) after losing the proxy fight. For a stock that has re-rated sharply, the insider signal is neutral-to-negative: those closest to the company are not adding, and the largest recent buyer is exiting.

Verdict: management has not allocated capital intelligently. Pro-cyclical buybacks, a large unproven acquisition (since impaired), size-tilted comp, and ~0.5% insider ownership are a weak record. The operational turnaround is to Super’s credit; the capital-stewardship record is not.

8. Changes and Headwinds — Last Two Years

The last two years contain the entire equity story, so this section is dense.

Leadership and strategy. Hillary Super became CEO on September 9, 2024, hired from Savage X Fenty — the first woman to run VS&Co as a public company. She unveiled the “Path to Potential” strategy in March 2025 (bra authority, PINK, beauty/sport/swim, brand projection) and instituted the “promo detox.” The Victoria’s Secret Fashion Show returned in October 2024 and 2025. In June 2026 the company rebranded its ticker to VSXY to signal the “next chapter.”

Operational inflection. Four consecutive positive-comp quarters (Q2 FY2025 through Q1 FY2026), culminating in the Q1 FY2026 blowout (comps +13%, adj. EPS $0.60 vs. ~$0.32 consensus, gross margin +240bps) and a raised FY2026 guide (sales $7.03–7.13B; adjusted operating income $550–580M).

The activist campaign (a full-blown proxy war). BBRC International (Brett Blundy) built a 13.0% stake (10.31M shares), switching from a passive to an active 13D and — via corrective Hart-Scott-Rodino filings — gaining the ability to go up to 49.99%. In response the board adopted a 15%-trigger poison pill (May 2025, ~one-year duration). A second activist, Barington Capital (James Mitarotonda), took a >1% stake. Together (~14%) they demanded removal of ~20-year Chair Donna James, refresh of up to six of nine directors, a board seat for Blundy, and a refocus on the core — attacking the 2022–23 buyback timing and the Adore Me deal. The board twice rejected Blundy’s candidacy and offered a settlement (an independent director + information-sharing) that Blundy refused. At the June 11, 2026 annual meeting, all nine incumbents were re-elected — Chair James with >83% of votes cast (>99% excluding BBRC) — with no board seats, standstill, or concessions granted. Management won cleanly; BBRC (still ~13%) and BlackRock (~13.8%) remain overhangs, and secondary sources reference an unconfirmed BBRC “acquisition proposal.”

Exogenous shocks. A cyberattack in May 2025 took the e-commerce site down for ~3 days (~$20M sales / $14M operating-income impact). Tariffs cut ~$85M of FY2025 operating income and ~$14M in Q1 FY2026 — an ongoing headwind given Asian sourcing.

Market-structure dynamics. Short interest reached ~22% of float (~10.7M shares) by late 2025, turning each earnings beat into a squeeze; David Einhorn’s Greenlight Capital disclosed a position and pitched VSXY at the Sohn Conference (May 2026).

Most recent developments (since the July-3 note). No new filings and no new quarter. Sell-side turned more constructive into the pullback — Morgan Stanley reinstated Overweight with a $99 target (July 6), adding to J.P. Morgan’s $88 — leaving Street targets above the stock. A supplier data point (Regina Miracle’s VS-driven profit lift, July 6) corroborates order momentum. The stock drifted from ~$88 to ~$78 with no fresh catalyst.

Verdict: net thesis effect is genuinely improving on operations but still precarious on price. The changes strengthen the operational case (real comps, real margin recovery, engaged board that survived a proxy war) but the investment case remains stretched, with the price at all-time-high multiples even after the give-back, the sponsoring activist selling, and the underlying share position still eroding.

9. Risk Analysis

Overall risk read: the dominant, near-certain risk is valuation — a high-beta, richest-ever-multiple stock priced for continued execution, layered on the operational risks that comps and margins are cyclically elevated and the structural risk of ongoing share loss. Catastrophic-loss risk is low (solvent, cash-generative), but the risk of a large drawdown from these levels is high — the stock has fallen 60–70% before (its 3-year max drawdown is ~−69%), and it has already given back ~11% from the June high.

10. Valuation Discussion (Embedded Expectations)

Where it trades. At ~$78 (~11.5% off the $88.50 all-time high), with ~79.4M basic / ~85M diluted shares, VSXY’s market cap is ~$6.2–6.7B and enterprise value (funded) is ~$7.0–7.3B (or ~$8.9–9.2B including capitalized leases). On that:

• Trailing P/E ~32x GAAP (on $2.44 TTM GAAP EPS; ~26x on headline adjusted EPS of $3.00; ~36–44x on “clean” adjusted EPS after normalizing the litigation gain and tax rate).
• Trailing EV/EBITDA ~13x (funded) on ~$557M TTM EBITDA; P/S ~0.97x; P/FCF ~high-teens to ~20x.
• Forward (FY2026 guide) EV/EBITDA ~9–10x (funded) and forward adjusted P/E ~19x (on ~$4.10–4.20 normalized-tax adjusted EPS).

Own-history and peer context — still richest-ever territory, still a premium to better businesses. On its own multi-year valuation history (2026-07-10, at $78.36): P/E is in the 99.2nd percentile and P/S in the 97.9th percentile of VSXY’s entire post-spin history — even after the pullback, the most expensive it has nearly ever been on earnings and sales (P/B is more middling at the 68th percentile, reflecting the tiny equity base). Against peers, the premium persists:

VSXY trades at a premium to every one of them on P/E and EV/EBITDA — including URBN, a genuinely growing, better-returning operator — despite flat five-year revenue and a share-losing position. Even on forward EBITDA, VSXY at ~9–10x sits at the top of a group that trades 7–9x. The ~11% pullback narrowed the trailing EV/EBITDA gap (from ~15–16x to ~13x) but did not eliminate the premium.

Embedded-expectations analysis — what must be true. The market is not pricing VSXY as a cyclical, no-moat, share-losing retailer; at ~$78 it is still pricing a durable earnings-power step-change. Working backward: to justify ~$78 at a “normal” apparel multiple of ~12x forward P/E, the market must believe VSXY can earn ~$6.50 of sustainable EPS — well above the FY2026 guide-implied adjusted EPS and roughly triple the “clean” trailing figure. Alternatively, at the FY2026 guide-implied ~$4.10–4.20 adjusted EPS, the market is paying ~19x — a premium multiple that assumes the margin recovery (operating margin from ~4% toward the 8%+ the guide implies) is permanent and that double-digit comps continue well beyond the easy-comparison window. In EV/EBITDA terms, ~13x trailing embeds EBITDA growth toward ~$800M+ and the maintenance of an above-peer multiple.

Scenario framework (illustrative; not price targets):

• Bear: comps fade toward flat, promo detox partially reverses, tariffs bite; adjusted EPS settles ~$3.00–3.50 and the multiple compresses to the peer ~10–12x → a valuation zone well below current, in line with the stock’s own pre-2026 history.
• Base: FY2026 guide is roughly met (~$4.10–4.20 adjusted EPS), comps decelerate to mid-single-digits thereafter, margin holds ~7–8%; a ~13–15x multiple on modestly growing earnings supports a valuation materially below ~$78 but above the trough.
• Bull: the turnaround proves structural — sustained high-single/low-double-digit comps, operating margin through 8–9%, share stabilizing — adjusted EPS compounds toward ~$5.00+ and the market keeps a ~18–20x growth multiple, supporting today’s price or higher.

The distribution is wide and the current price still sits near the bull end. This section states no price target and no recommendation — only that at ~$78 the market is underwriting the bull scenario as the base case, with little margin of safety if execution merely normalizes.

11. Variant Perception

Consensus view (as embedded in the price and analyst targets, now $88–$99): VSXY is a successful, durable turnaround — a beloved brand reclaiming relevance under a credible new CEO, with four straight positive-comp quarters, expanding margins, international runway, and takeover optionality from a 13% activist — worthy of a growth multiple. That sell-side conviction actually firmed into the July pullback (Morgan Stanley reinstating Overweight at $99), a tell that consensus reads the give-back as an entry, not a warning.

Strongest bull case. The promo detox is a structural gross-margin reset, not a one-quarter trick; operating margin has real room to recover toward the high-single digits it earned before (12.8% at the FY2022 peak), so even flat revenue drives large EPS growth. International (especially China) and beauty/sport add genuine top-line optionality. The balance sheet is sound, FCF funds buybacks, and the ~22%-short, activist-contested float plus unconfirmed BBRC takeover interest give an asymmetric right tail. On forward adjusted EPS the stock is “only” ~19x for a business inflecting from trough margins — cheaper than a fortnight ago.

Strongest bear case. This is a share-losing incumbent (~33%→~20%) in a low-barrier, promotional category, whose core NA stores and DTC channel are flat-to-down and whose growth is a small, reclassification-flattered international line. The moat is a fading brand with no pricing power; the acquisition meant to fix the digital gap (Adore Me) has been written down 30%. Trailing earnings are one-time-flattered (a $69M gain + a 9% tax rate); the recovery is comping depressed bases and may be cyclical. The stock is at near-richest-ever multiples and a premium to cheaper, better peers; capital allocation is poor; insiders own ~0.5% and have bought nothing; and the sponsoring activist is now selling into strength. When the comp/margin tailwind lapses, a 5x-in-11-months, high-beta name with a −69% drawdown history de-rates hard — and the ~11% July slide, on no news, is a reminder of how quickly the squeeze premium can bleed.

The 3–5 assumptions that matter most:

1. Are the margin gains durable or cyclical? (Promo detox permanence vs. category promotional reversion.)
2. Can comps stay positive past the easy-comparison window without renewed promotion?
3. Does share stabilize against Aerie/Skims/Savage, or keep eroding?
4. Does the activist/takeover optionality resolve into a bid — or into 13% of supply for sale?
5. What tax rate and one-time-adjusted base should the market capitalize? (Headline $3.00 vs. clean ~$2.00 vs. GAAP $2.44.)

Falsification tests. Bull is falsified if comps decelerate toward flat or gross margin gives back its gains over the next 2–3 quarters, or if tariffs re-compress operating margin below ~6%. Bear is falsified if VSXY delivers a full year of positive comps with operating margin sustained above 8% and evidence (share data, DTC re-acceleration) that it is taking share back — proof of restored pricing power rather than a cyclical bounce.

Factor-positioning read (the tape). A quantitative factor model (refreshed 2026-07-14) is unchanged in character: VSXY loads on Market (~1.4β), Retail industry, and SmallSize, but on no style factor — Momentum, Value, Quality, Growth, and LowVol all zeroed — with a low R² and idiosyncratic (specific) volatility near ~69% annualized. This move is almost entirely single-name — a special situation (turnaround + squeeze + activist), not a crowded factor trade. The trailing-1-year return has eased with the pullback to ~+321% annualized (Sharpe ~4.1) from ~+386%, while the three-year maximum drawdown remains −69%. This is a high-beta, low-quality-of-trend, idiosyncratic re-rating with a documented history of 60–70% drawdowns — the empirical signature of a stock where consensus enthusiasm and price have outrun a structurally challenged business. The tape supports the bear’s “priced for perfection” read more than the bull’s “durable compounder” one.

12. Fact vs. Interpretation Table

13. Open Questions

1. Beauty revenue and margin — undisclosed (single-segment reporting). How large and how profitable is the “industry-leading” beauty attach business?
2. Organic vs. reclassification split of the +27% International growth — how much is real, given the Q3-2025 direct-fulfillment reclassification?
3. Sustainability of the promo detox — can VSXY hold higher AURs/lower promotion as comparisons harden and competitors stay promotional?
4. Did the STIP adjusted-operating-income base exclude the $69M litigation gain? (Comp-quality/governance question.)
5. BBRC’s intentions — does the ~13% holder keep selling, or resurface with a bid? Is the reported “acquisition proposal” real?
6. Normalized tax rate and run-rate margin — what operating margin is genuinely sustainable versus cyclically elevated by easy comps and one-time items?
7. Current NA intimates share trajectory — is VSXY actually stabilizing share, or still ceding it while comps rise off a low base?
8. Q2 FY2026 (reports ~late Aug): does the comp/margin cadence hold once the easiest comparisons begin to lap — the first real test of the thesis since this note?

14. What Must Be True

Bull case — what must be true:

• The margin recovery is structural: operating margin holds ≥8% (toward the FY2026 guide) through a full cycle, proving the promo detox restored real pricing power.
• Comps stay positive (mid-single-digit or better) after lapping the easy 2025 comparisons, without re-promoting.
• Share stabilizes against Aerie/Skims/Savage; International and beauty add genuine, ongoing growth.
• The FY2026 guide (sales $7.03–7.13B, adj. op income $550–580M) is met or beaten, and the market keeps an ~18–20x multiple.
• Falsification test: two-plus consecutive quarters of decelerating comps toward flat, or gross margin giving back 100bps+, or operating margin falling below ~6% on tariffs — any of which breaks the “durable step-change” thesis.

Bear case — what must be true:

• The recovery is cyclical: comps decelerate toward flat as comparisons harden, and the promo detox partially reverses under competitive pressure.
• Share keeps eroding; the core NA store/DTC stagnation persists; International growth normalizes once the reclassification laps.
• The market re-rates VSXY toward the apparel-peer band (~9–12x P/E, ~7–9x EV/EBITDA) as trailing earnings normalize (off the one-time gain and low tax rate) and the activist supply (13%) weighs.
• Falsification test: a full fiscal year of positive comps with operating margin sustained above 8% and evidence (share data, DTC re-acceleration) of share gains — proof the business has genuinely re-moated, which would invalidate the “no durable advantage / cyclical bounce” thesis.

15. Source Appendix

See Appendix B for the full, categorized source list with URLs and access dates. Primary sources include: the FY2025 10-K (fiscal year ended January 31, 2026; filed March 20, 2026); the Q1 FY2026 10-Q (quarter ended May 2, 2026); the 2026 DEF 14A and the 2025–26 contested-proxy filings; Form 4 insider filings (CIK 1856437); the Q1 FY2026 earnings call transcript (June 2, 2026); public market and valuation data; and press coverage (the Morgan Stanley $99 reinstatement and the Regina Miracle supplier note, both July 6, 2026). External industry and competitor data are attributed inline.

APPENDIX A — Standard Diligence Questionnaire

Supplemental to the memo. Fact / Interpretation / Assumption labels used where material. This is an UPDATE of the 2026-07-03 questionnaire; substance is unchanged (no new quarter/filings), with price/valuation refreshed to ~$78 (July 10, 2026 close).

General

What thoughtful questions have other investors asked about this company? Whether the FY2025→2026 comp/margin recovery is structural or a cyclical bounce off depressed comparisons; whether the promo detox holds as comparisons harden; whether Adore Me (~$591M, since impaired $120M) was value-destructive; whether the ~$625M of 2022–23 buybacks-at-highs then dormancy-at-lows disqualifies management on capital allocation; whether BBRC’s ~13% stake resolves into a takeover bid or into supply for sale; and — most of all — whether a near-richest-ever ~32x trailing P/E is justified for a share-losing incumbent. Sell-side has grown more bullish into the July pullback (Morgan Stanley reinstated Overweight at $99; J.P. Morgan at $88). (Interpretation, from the activist filings, Einhorn’s Sohn pitch, and sell-side notes.)

Cyclicality & Earnings Nature

Cyclical high or low? Earnings are recovering off a cyclical/operational trough (FY2024 net income $109M) but are being flattered by one-time items (a $69M litigation gain, a 9.2% tax rate). Margins remain below the business’s own historical mid-cycle (op margin ~4% GAAP vs. 12.8% at the FY2022 stimulus peak), so earnings are neither at a clean high nor a clean low — they are mid-recovery with quality caveats. (Fact + Interpretation.) Driven by external environment or internal actions? Both: internal (new CEO, promo detox, PINK/beauty focus) and external (post-stimulus normalization ending, easy comparisons, tariffs as a headwind). (Interpretation.) How stable are revenues? Flat at $6.2–6.8B for five years; discretionary and seasonally concentrated (Q4 holiday ≈ 35% of sales and most of profit). Not stable growth — stable stagnation. (Fact.) Outlook for products/services; market size/growth? US lingerie ~$18–24B, growing ~4.5–7%; global. VSXY is losing share (~33%→~20%) in that growing market. (Fact/external estimate.)

Business Quality & Competitive Moat

Industry getting more or less competitive? More — a wave of low-barrier DTC insurgents (Aerie, Skims, Savage X Fenty, ThirdLove, Knix) plus mass/marketplace pressure. (Interpretation, capital-cycle framing.) How profitable (ROIC, ROE)? ROIC ~6.5% (≈ cost of capital); reported ROE ~38%+ is a balance-sheet artifact of tiny/near-zero equity, not a quality signal. TBV/share ~$3.71 (negative in prior years). (Fact.) How profitable is the industry; barriers to entry? Low barriers, promotional, mid-30s gross margins for the leader; fragmented. (Fact/Interpretation.) Easily understood? Yes — a mall-based intimates retailer with a franchise/e-commerce overlay. (Fact.) Undermined by foreign low-cost labor? Product is sourced from Asia (tariff-exposed; the July-2026 Regina Miracle supplier note underscores the Asian OEM base); the retail brand/store franchise is the differentiator, not manufacturing. (Fact.) Do brands matter? Yes, but VSXY’s brand is a weakened intangible with no pricing power (heavy promotion). (Interpretation.) Nature of competition; switching costs? Brand/fashion/price competition; near-zero switching costs. (Interpretation.)

Financial Condition & Balance Sheet

Assets not fully on the balance sheet? The brand/IP is largely internally generated and not capitalized; conversely, ~$1.8–1.9B of lease liabilities are on the balance sheet. (Fact.) Off-balance-sheet liabilities? None material beyond leases (already on-balance-sheet under ASC 842). (Fact.) How conservative is the accounting? Mixed — a $120M Adore Me impairment was appropriately taken, but the non-GAAP “adjusted” framing carries a $69M one-time gain and benefits from a sub-10% tax rate; treat headline adjusted EPS with caution. (Interpretation.) How CapEx-hungry? Moderate: capex ~$187M (~2.9% of sales); fleet is contracting, so growth capex is limited. FCF ~$312M (FY2025); ROIC TTM FCF-to-firm ~$574M. (Fact.)

Capital Allocation & Management

FCF generation and use? ~$312M FCF FY2025; used for Adore Me earnout payments, deleveraging, and (resumed in Q1 FY2026) $100M of buybacks at ~$45. No dividend. (Fact.) Significant recent acquisitions? Adore Me (~$591M all-in, 2022/23) — since impaired $120M. (Fact.) Buying back shares? $250M authorization (Mar 2024) largely unused; ~$625M bought at 2022–23 highs; $100M repurchased Q1 FY2026, ~$150M remaining. Pattern is pro-cyclical. (Fact/Interpretation.) Issuing shares to insiders? SBC ~$55M/yr; share count roughly flat (~79–85M); insider ownership only ~0.5%. (Fact.) Compensation policy / motivations? CEO $14.4M FY2025; STIP 75% adjusted operating income / 25% net sales — size/scale-tilted, not per-share/ROIC. Thin insider ownership; no open-market management buying on the 5x run. (Fact/Interpretation.)

Valuation & Market Data

ADR/MLP/K-1? No — US common stock, NYSE (symbol VSXY since June 2, 2026), single class. (Fact.) Dividend policy? No dividend since the 2021 spin. (Fact.) How profitable? Modestly — ~4% GAAP / ~6% adjusted operating margin; ~6.5% ROIC. (Fact.) Net income diverging from cash from operations? OCF ($499M) exceeds net income ($161M), typical of a D&A-heavy retailer; FCF (~$312M) is healthy and real. No red-flag divergence. (Fact.)

Risks & Downside

What would cause the stock to decline? Multiple de-rating from near-richest-ever levels; comp/margin deceleration; tariff escalation; activist (13%) selling; recession. The ~11% July give-back on no news illustrates how quickly the squeeze premium can bleed. (Interpretation.) Catastrophic-loss risk? Low — solvent, FCF-positive, undrawn revolver, no near-term maturities. (Fact/Interpretation.) Chance of total loss? Very low near-term; the risk is a large drawdown (3-yr max drawdown −69%), not insolvency. (Interpretation.)

Recent News & Events

Has the business environment changed recently? Not in the last 11 days — no new filings, no new quarter (Q2 FY2026 reports ~late Aug). Over the last two years: a CEO change (Sept 2024), “Path to Potential,” promo detox, four positive-comp quarters, a Q1 FY2026 blowout and raised guidance, a contested proxy fight (management won June 11, 2026), a ticker change to VSXY (June 2, 2026), a May-2025 cyberattack, and ongoing tariffs. Most recent items: Morgan Stanley Overweight reinstatement ($99, July 6) and a Regina Miracle supplier-profit note (July 6). (Fact.) Significant acquisitions / accounting-policy changes? Adore Me impairment; International-channel reclassification (Q3 2025). (Fact.) Recent changes — new markets/facilities/management? New CEO/CFO; China JV now profitable; international franchise expansion; fleet optimization. (Fact.)

APPENDIX B — Source Appendix

Primary sources over secondary; all figures reconciled to filings where possible. This is an UPDATE of the 2026-07-03 appendix; quantitative services refreshed 2026-07-14 unless noted. No new SEC filings were made between 2026-07-03 and 2026-07-14 (EDGAR since query empty). Accessed 2026-07-14 unless noted.

Primary — SEC filings (CIK 0001856437)

• FY2025 Form 10-K (fiscal year ended Jan 31, 2026; filed 2026-03-20) — net sales disaggregation, store-count/productivity tables, GAAP-to-adjusted operating-income reconciliation ($120M Adore Me impairment, $36M restructuring, $69M interchange gain), debt note (4.625% notes due 2029; term loan; ABL), China JV/NCI, tax note (9.2% rate; $24M VA release), buyback/financing. https://www.sec.gov/Archives/edgar/data/1856437/000185643726000004/vsco-20260131.htm
• Q1 FY2026 Form 10-Q (quarter ended May 2, 2026; filed 2026-06-05) — Q1 comps +13%, GM +240bps, $100M buyback at ~$45, interim cash/debt. https://www.sec.gov/Archives/edgar/data/1856437/000185643726000013/vsco-20260502.htm
• 2026 DEF 14A (filed ~2026-05-01) — Summary Compensation Table, STIP/LTI metrics, beneficial ownership. https://www.sec.gov/Archives/edgar/data/1856437/000119312526201438/vsco-20260430.htm
• Contested-proxy record (2025–26): DEFC14A / PREC14A / PRRN14A / DFAN14A (BBRC) and company DEFA14A responses; SC 13D/13D-A (BBRC). EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001856437&type=&dateb=&owner=include&count=100
• Form 3/4/5 insider corpus — insider transaction-code parse (grants/tax-withholding vs. BBRC open-market buys Mar–Apr 2025 and sells Jun 2026). Most recent Form 4 filed 2026-06-30. https://data.sec.gov/submissions/CIK0001856437.json
• 8-K, 2026-05-21 — NYSE ticker change VSCO→VSXY (effective 2026-06-02). https://www.sec.gov/Archives/edgar/data/0001856437/000185643726000007/ex991vscomay212026pressrel.htm
• 8-K, 2025-05-20 — limited-duration shareholder rights plan (15% trigger).

Primary — company disclosures & transcript

• Q1 FY2026 earnings call transcript (2026-06-02) — comps +13%, adj. op income +153% to $80M, adj. EPS $0.60, gross margin +240bps to 37.6%, international +36%, ~$14M/90bps tariff, buyback 2.2M sh/$100M @ ~$45, raised guidance.
• Q4/FY2025 earnings release (2026-03-05) — FY2025 adj. EPS $3.00, adj. op income $403M, ~$85M tariff drag; FY2026 guide.
• Q3 FY2025 release (Dec 2025) — sales $1.472B (+9%), comps +8%, raised FY adj. op-income guide.
• Company release — shareholders re-elect all nine directors (2026-06-11). https://www.victoriassecretandco.com/news-releases/news-release-details/victorias-secret-co-shareholders-decisively-re-elect-all-nine
• Company release — ticker change to VSXY. https://www.victoriassecretandco.com/news-releases/news-release-details/victorias-secret-co-change-ticker-symbol-vsxy-marking-next

Market & valuation data (as of 2026-07-14)

• Financial statements & ratios — income statement, balance sheet, cash flow, profitability/credit/per-share ratios, enterprise value (TTM through Q1 FY2026: net sales $6,760M, EBITDA $557M, oper inc $327M, TTM FCF ~$574M; ~79.4M shares), valuation multiples (VSXY + peers AEO/GAP/URBN), reconciled to filings.
• Price & own-history valuation — 5-year price/OHLCV history (ATL $14.30 2023-10-05; 52wk low $17.70 2025-07-16; ATH $88.50 2026-06-26; last close $78.36 2026-07-10); own-history valuation percentiles (2026-07-10, at $78.36): P/E 32.09 (99th pctile), P/B 8.42 (68th), P/S 0.97 (98th); TTM GAAP EPS $2.44.
• Factor/positioning model (2026-07-14) — loadings (Market ~1.4β, Retail, SmallSize; no style factors; low R²), risk-adjusted track record (1-yr +321% ann., Sharpe ~4.1, max DD −35.6%; 3-yr +60.6% ann., Sharpe 0.82, max DD −69.5%), beta 1.41, relative strength rs_12m +292%, ~11.5% off peak.

Secondary — industry, competitor & event context

• Statista — Victoria’s Secret topic (2016 peak revenue ~$7.78B). https://www.statista.com/topics/4819/victoria-s-secret/
• Grand View Research — US lingerie market ($18–24B; CAGR). https://www.grandviewresearch.com/industry-analysis/us-lingerie-market-report
• CNBC (2024-03-07) — VS falls as shrinking demand hits sales forecasts (share erosion). https://www.cnbc.com/2024/03/07/victorias-secret-falls-as-shrinking-demand-hits-sales-forecasts.html
• AEO Investor Relations — Q4 FY2025 results (Aerie ~$1.7B+, comps). https://investors.ae.com/press-releases
• CNBC (2025-11-12) — Skims $5B valuation round. https://www.cnbc.com/2025/11/12/skims-5-billion-valuation-funding-round.html
• Forbes (2024-08-14) — Hillary Super named CEO (ex-Savage X Fenty). https://www.forbes.com/sites/maryroeloffs/2024/08/14/victorias-secret-shares-surge-as-firm-hires-former-savage-x-fenty-exec-as-new-ceo/
• Retail Dive — investors back board over BBRC. https://www.retaildive.com/news/victorias-secret-investors-back-board-proxy-fight-bbrc/823012/
• StockTitan — proxy vote result; BBRC Form 4 sale at $88.50. https://www.stocktitan.net/news/VSCO/
• Press coverage (2026-07-06) — Morgan Stanley reinstates Overweight on Victoria’s Secret, $99 price target; Regina Miracle International profit boosted by its Victoria’s Secret partnership (supplier read-through).
• J.P. Morgan (2026-06-08) — maintains Overweight, raises price target to $88.